MICHAEL J. BASKER

Statistics

Publications

Citations

608

H-Index

Active since

1974

Affiliations

Molecular Discovery (United Kingdom)(Current)

New Frontier

MICHAEL J. BASKER is an author at Molecular Discovery (United Kingdom) specializing in microbiology, antibacterial pharmacology, and antibiotic resistance.

Publications per year

1974–2009

Publications

BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans

B Slocombe, MICHAEL J. BASKER, P. H. BENTLEY et al. · Antimicrobial Agents and Chemotherapy · 1981 · 129 citations · Full text

Life Sciences, Microbiology, Pharmacology +13

Synergy Between Ticarcillin and Tobramycin Against <i>Pseudomonas aeruginosa</i> and <i>Enterobacteriaceae</i> In Vitro and In Vivo

K. R. Comber, MICHAEL J. BASKER, Christine D. Osborne et al. · Antimicrobial Agents and Chemotherapy · 1977 · 54 citations · Full text

Life Sciences, Microbiology, Pharmacology +15

In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin

MICHAEL J. BASKER, Robert Edmondson, SARAH J. KNOTT et al. · Antimicrobial Agents and Chemotherapy · 1984 · 47 citations · Full text

Life Sciences, Microbiology, Pharmacology +15

Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes

MICHAEL J. BASKER, Robert Edmondson, R. Sutherland · Infection · 1979 · 46 citations

Life Sciences, Infectious Diseases, Microbiology +14

Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.

MICHAEL J. BASKER, Ron Boon, Pamela Hunter · The Journal of Antibiotics · 1980 · 46 citations · Full text

Medicine, Microbiology, Pharmacology +10

1–5 of 20